NCT07501312

Brief Summary

This study will compare far-field speech understanding in noise using a hearing aid alone, with using a hearing aid plus a Roger remote microphone. It will also compare the HA+Roger mic to two other manufacturers' hearing aids plus remote mic systems in the same condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 24, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

March 25, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 30, 2026

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 21, 2026

Completed
Last Updated

May 29, 2026

Status Verified

March 1, 2026

Enrollment Period

27 days

First QC Date

March 24, 2026

Last Update Submit

May 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • AZ Bio Sentence Test

    Validated test of speech intelligibility in which participants repeat as many words as they can from a presented list of 20 sentences. Words correct are calculated as a percent correct from the total number of words presented. Higher percentages mean better speech intelligibility.

    Visit 2, Day 2 of study

Study Arms (6)

Phonak device first, then Device A, then Device B

EXPERIMENTAL

Participants fit and tested with Phonak devices first, then Devices A, then Devices B

Device: PhonakDevice: Device ADevice: Device B

Phonak device first, then Device B, than Device A

EXPERIMENTAL

Participants fit and tested with Phonak device first, then Device B, then Device A

Device: PhonakDevice: Device ADevice: Device B

Device A first, than Phonak devices, then Device B

EXPERIMENTAL

Participants fit and tested with Device A first, than Phonak device, then Device B

Device: PhonakDevice: Device ADevice: Device B

Device A first, than Device B, then Phonak devices

EXPERIMENTAL

Participants fit and tested with Device A first, than Device B, then Phonak devices

Device: PhonakDevice: Device ADevice: Device B

Device B, than Phonak devices, than Device A

EXPERIMENTAL

Participants fit and tested with Device B first, than Phonak devices, then Device A

Device: PhonakDevice: Device ADevice: Device B

Device B first, then Device A, then Phonak devices

EXPERIMENTAL

Participants fit and tested with Device B first, then Device A, then Phonak devices

Device: PhonakDevice: Device ADevice: Device B

Interventions

PhonakDEVICE

Phonak hearing aid, either used alone or with the compatible remote microphone

Device A first, than Device B, then Phonak devicesDevice A first, than Phonak devices, then Device BDevice B first, then Device A, then Phonak devicesDevice B, than Phonak devices, than Device APhonak device first, then Device A, then Device BPhonak device first, then Device B, than Device A
Device ADEVICE

First competitor hearing aid, either used alone or with compatible remote microphone

Device A first, than Device B, then Phonak devicesDevice A first, than Phonak devices, then Device BDevice B first, then Device A, then Phonak devicesDevice B, than Phonak devices, than Device APhonak device first, then Device A, then Device BPhonak device first, then Device B, than Device A
Device BDEVICE

Second competitor hearing aid, either used alone or with compatible remote microphone

Device A first, than Device B, then Phonak devicesDevice A first, than Phonak devices, then Device BDevice B first, then Device A, then Phonak devicesDevice B, than Phonak devices, than Device APhonak device first, then Device A, then Device BPhonak device first, then Device B, than Device A

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Bilateral sensorineural hearing loss
  • Experienced bilateral hearing aid users
  • Fluent in English, ability to read and write in English
  • Able to produce a reliable study result
  • Willing to comply with all study requirements

You may not qualify if:

  • Limited/inconsistent/no prior use of hearing aids
  • Self-reported ear-related pathology(including but not limited to: otorrhea within the past 90 days, dizziness, sudden onset or worsening hearing loss within the past 90 days, otalgia)
  • Visible deformity of the ear
  • Chronic, severe tinnitus
  • Unilateral hearing loss
  • Single sided deafness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sonova US Corporate Services

Aurora, Illinois, 60504, United States

Location

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will be blinded as to which devices they are fitted with during the testing.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2026

First Posted

March 30, 2026

Study Start

March 25, 2026

Primary Completion

April 21, 2026

Study Completion

April 21, 2026

Last Updated

May 29, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations